1- Eyadhy AA, Razack S. The ethics of using innovative therapies in the care of children. Paediatr Child Health. 2008 Mar;13(3):181-4. doi: 10.1093/pch/13.3.181.

2 - The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: Ethical principles and guidelines for the protection of human subjects of research. Washington: Office for Protection from Research Risks Reports, 1979.

3- Fost N. Ethical issues in research and innovative therapy in children with mood disorders. Biol Psychiatry. 2001 Jun 15;49(12):1015-22. doi: 10.1016/s0006-3223(01)01181-7.

4- Advanced therapy medicinal products [Internet]. EATRIS. 2022 [cited 2022Oct12]. Available from: https://eatris.eu/atmp/

5- YouTube. YouTube; 2013 [cited 2022Oct12]. Available from: https://www.youtube.com/watch?v=IxsrRTcdXro&list=PLbTBF__p6d_IL6YRgJYOCBgsv2YO9TA2-

6- Cell therapy [Internet]. Alliance for Regenerative Medicine. 2019 [cited 2022Oct12]. Available from: https://alliancerm.org/technologies/cell-therapy/

7- Gene-based medicine [Internet]. Alliance for Regenerative Medicine. 2020 [cited 2022Oct12]. Available from: https://alliancerm.org/technologies/gene-based-medicine/

8- Genome editing [Internet]. Alliance for Regenerative Medicine. 2018 [cited 2022Oct12]. Available from: https://alliancerm.org/technologies/genome-editing/

9- Genome editing [Internet]. Alliance for Regenerative Medicine. 2020 [cited 2022Oct12]. Available from: https://alliancerm.org/bioethics/

10- Tissue engineering and regenerative medicine [Internet]. National Institute of Biomedical Imaging and Bioengineering. U.S. Department of Health and Human Services; [cited 2022Oct12]. Available from: https://www.nibib.nih.gov/science-education/science-topics/tissue-engineering-and-regenerative-medicine

11- Tissue-engineered products & Biomaterials [Internet]. Alliance for Regenerative Medicine. 2018 [cited 2022Oct12]. Available from: https://alliancerm.org/technologies/tissue-engineered-products-biomaterials/

12- Regenerative Medicine: The Pipeline Momentum Builds - September 2022 [Internet]. Alliance for regenerative medicine. Alliance for regenerative medicine; 2022 [cited 2022Oct12]. Available from: https://alliancerm.org/

13- Fidler B. 'The music stopped': Biotech rout leaves drug startups grounded as demand slumps for ipos [Internet]. BioPharma Dive. BioPharma Dive; 2022 [cited 2022Oct12]. Available from: https://www.biopharmadive.com/news/biotech-ipo-venture-startup-investors-market-downturn/618205/

14- Mueller J, Tregrossi A, Meylan J. Current status and future developments in innovative therapy funding in Switzerland [Internet]. Simon Kucher . Simon-Kucher & Partners ; [cited 2022Oct12]. Available from: https://www.simon-kucher.com/de/blog/current-status-and-future-developments-innovative-therapy-funding-switzerland

15- Hanna E, Toumi M, Dussart C, Borissov B, Dabbous O, Badora K, Auquier P. Funding breakthrough therapies: A systematic review and recommendation. Health Policy. 2018 Mar;122(3):217-229. doi: 10.1016/j.healthpol.2017.11.012

16 - Berger ML, Sox H, Willke RJ, et al. Good Practices for Real‐World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR‐ISPE Special Task Force on Real‐World Evidence in Health Care Decision Making. Value in Health. 2017;20(8):1003-1008.

17 - Katkade VB, Sanders KN, Zou KH. Real world data: an opportunity to supplement existing evidence for the use of long-established medicines in health care decision making. J Multidiscip Healthc. 2018 Jul 2;11:295-304. doi: 10.2147/JMDH.S160029.

18 - Sekaran, U. and Bougie, R. (2016) Research Methods for Business: A Skill-Building Approach. 7th Edition, Wiley & Sons, West Sussex